F
F. Pons
Researcher at University of Barcelona
Publications - 19
Citations - 2695
F. Pons is an academic researcher from University of Barcelona. The author has contributed to research in topics: Liver transplantation & Hepatocellular carcinoma. The author has an hindex of 11, co-authored 19 publications receiving 2582 citations.
Papers
More filters
Journal ArticleDOI
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 IMPLICATIONS FOR CROHN′S DISEASE
Naohiro Inohara,Yasunori Ogura,Ana Fontalba,Olga Gutierrez,F. Pons,Javier Crespo,Koichi Fukase,Seiichi Inamura,Shoichi Kusumoto,Masahito Hashimoto,Simon J. Foster,Anthony P. Moran,Jose L. Fernandez-Luna,Gabriel Núñez +13 more
TL;DR: NOD2 mediates the host response to bacterial muropeptides derived from peptidoglycan, an activity that is important for protection against Crohn's disease and has implications for understanding adjuvant function and effective vaccine development.
Journal ArticleDOI
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
Margarita Sala,Josep Fuster,Josep M. Llovet,Miquel Navasa,Manel Solé,Maria Varela,F. Pons,Antoni Rimola,Juan Carlos García-Valdecasas,Concepció Brú,Jordi Bruix +10 more
TL;DR: It is confirmed that pathological parameters identify patients at higher risk of recurrence, which allow them to be listed for liver transplantation without proven malignant disease, and could further improve the outcome of resected patients.
Journal ArticleDOI
Staging systems in hepatocellular carcinoma
TL;DR: The conventional staging systems for hepatocellular carcinoma (HCC), such as the Okuda stage or the TNM stage have shown important limitations in classifying patients, and several new systems have been proposed recently, but only three have been validated at this point.
Journal ArticleDOI
Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity: A prospective series from Spain
M. Isabel Lucena,Raúl J. Andrade,M. Carmen Fernández,Ketevan Pachkoria,G. Pelaez,José Antonio Durán,Macarena Villar,Luis Rodrigo,Manuel Romero-Gómez,Ramon Planas,A.M. Barriocanal,Joan Costa,Carlos Guarner,S. Blanco,J.M. Navarro,F. Pons,Agustin Castiella,Susana Avila +17 more
TL;DR: Age is the most important determinant in the biochemical expression of AC hepatotoxicity; younger age is associated with cytolytic damage and shorter treatment duration, whereas cholestatic/mixed type of damage is related to older age and prolonged AC therapy.
Journal ArticleDOI
Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality.
TL;DR: Chronic renal dysfunction is an important cause of morbidity after OLT, although end-stage renal disease is infrequent and efforts should be made to avoid early renal dysfunction after liver transplantation.